202 related articles for article (PubMed ID: 6878054)
21. [Results of a cytostatic combination treatment of metastasized breast and small cell bronchial carcinoma during partial blockade of the cell cycle].
Ammon J; Kreidler J; Goronzy J
Strahlentherapie Sonderb; 1978; 75():126-33. PubMed ID: 233454
[No Abstract] [Full Text] [Related]
22. Long-term survivorship in small-cell anaplastic lung carcinoma.
Ginsberg SJ; Comis RL; Gottlieb AJ; King GB; Goldberg J; Zamkoff K; Elbadawi A; Meyer JA
Cancer Treat Rep; 1979 Aug; 63(8):1347-9. PubMed ID: 225029
[No Abstract] [Full Text] [Related]
23. [Combined chemotherapy and radiotherapy for localized small cell pulmonary carcinoma].
Reiss J; Haim N; Robinson E
Harefuah; 1982 May; 102(9):370-2. PubMed ID: 6298078
[No Abstract] [Full Text] [Related]
24. Heparin and polychemotherapy for treatment of lung cancer.
Rohwedder JJ; Sagastume E
Cancer Treat Rep; 1977 Oct; 61(7):1399-401. PubMed ID: 589603
[No Abstract] [Full Text] [Related]
25. [Chemotherapy in advanced cancer of the lung].
Fleischer I; Wainstein R; Jovtis SL; Gibson AM; Barousse AP
Medicina (B Aires); 1979; 39(4):472-6. PubMed ID: 545078
[No Abstract] [Full Text] [Related]
26. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
[TBL] [Abstract][Full Text] [Related]
27. Combination chemotherapy with adriamycin, cyclophosphamide, methotrexate and vincristine in lung cancer patients with extensive disease.
Kolarić K; Roth A; Vukas D
Tumori; 1979 Oct; 65(5):635-42. PubMed ID: 229601
[No Abstract] [Full Text] [Related]
28. Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer.
Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK; Coles DT
Cancer Treat Rep; 1981; 65(7-8):715-7. PubMed ID: 6166376
[No Abstract] [Full Text] [Related]
29. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
30. Phase II evaluation of the combination of triazinate, cyclophosphamide, doxorubicin, and cis-diamminedichloroplatinum(II) in patients with advanced adenocarcinoma of the lung.
Eagan RT; Frytak S; Ingle JN; Creagan ET; Nichols WC; Kvols LK
Cancer Treat Rep; 1980; 64(8-9):925-8. PubMed ID: 7192602
[TBL] [Abstract][Full Text] [Related]
31. New polychemotherapy regimen for head and neck tumors: pilot study.
Pannuti F; Cricca A; Fruet F; Burroni P; Rossi AP
Cancer Treat Rep; 1979 May; 63(5):805. PubMed ID: 455321
[No Abstract] [Full Text] [Related]
32. Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.
Eagan RT; Ingle JN; Frytak S; Rubin J; Kvols LK; Carr DT; Coles DT; O'Fallon JR
Cancer Treat Rep; 1977 Oct; 61(7):1339-45. PubMed ID: 589599
[No Abstract] [Full Text] [Related]
33. A role of cis-dichlorodiammineplatinum(II) in squamous cell lung cancer.
Eagan RT; Fleming TR; Frytak S; Creagan ET; Ingle JN; Kvols LK
Cancer Treat Rep; 1980 Jan; 64(1):87-91. PubMed ID: 6991107
[TBL] [Abstract][Full Text] [Related]
34. [Palliative chemotherapy of adult soft tissue sarcomas with an association of cyclophosphamide-vincristine-adriamycine-dacarbazine (CYVADIC) (author's transl)].
Bui B; Chauvergne J; Durand M; Brunet R
Bull Cancer; 1981; 68(1):1-5. PubMed ID: 7225604
[TBL] [Abstract][Full Text] [Related]
35. Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer.
Leighl NB; Goss GD; Lopez PG; Burkes RL; Dancey JE; Rahim YH; Rudinskas LC; Pouliot JF; Rodgers A; Pond GR; Shepherd FA
Lung Cancer; 2006 Jun; 52(3):327-32. PubMed ID: 16597474
[TBL] [Abstract][Full Text] [Related]
36. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
Vogelzang NJ; Bonomi PD; Rossof AH; Wolter J
Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563
[No Abstract] [Full Text] [Related]
37. Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinoma.
Evans WK; Feld R; DeBoer G; Osoba D; Curtis JE; Baker MA; Myers RE; Quirt IC; Pritchard KI; Brown TC; Kutas GJ; Blackstein ME; Ottema B; Millband L
Cancer Treat Rep; 1981; 65(11-12):947-54. PubMed ID: 7028256
[TBL] [Abstract][Full Text] [Related]
38. [Polychemotherapy for advanced epidermoid cell lung cancer (author's transl)].
Kokron O
Wien Klin Wochenschr; 1982 Jan; 94(1):1-5. PubMed ID: 7080489
[TBL] [Abstract][Full Text] [Related]
39. Combination of levamisole immunotherapy and polychemotherapy in advanced breast cancer.
Klefström P
Cancer Treat Rep; 1980 Jan; 64(1):65-72. PubMed ID: 6991105
[TBL] [Abstract][Full Text] [Related]
40. [Combination chemotherapy of primary gastric lymphoma with vincristine, endoxan (cyclophosphamide), prednisolone and adriamycine (VEPA)].
Takenaka T; Konda C; Sakano T; Shimoyama M; Kitahara T; Minato K; Kitaoka H
Gan To Kagaku Ryoho; 1982 Feb; 9(2):323-9. PubMed ID: 6897859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
